CUV 0.33% $15.16 clinuvel pharmaceuticals limited

It’s the “enigmatic” “wasted years and EPP opportunity” and...

  1. 69 Posts.
    lightbulb Created with Sketch. 25

    It’s the “enigmatic” “wasted years and EPP opportunity” and “glacial” history of this company “with so much potential” and the realisation that the conductor, that’s been in total control of this lacklustre performance (for 20 years already!)seemingly with no intention of doing whats necessary to speed up the tempo of his masterpiece, that is at the heart of the uncertainty and frustration and lack of interest here.


    This is what has been making some people nervous for a long time now and one of the reasons keeping investors from purchasing a stake in all this “perplexing” frustration and insanity……… can’t wait for the new zinc paste suncream line though….. Absolutely brilliant idea! …..A real game changer!


    A concert hall that should be full of enthusiastic supportive patrons is bare with only the regulars left seething and praying for a change of tune…….. I reckon a $50 refund tomorrow would see the concert hall quickly empty.


    Will the lure of (what looks to be 90ish % effective) vitiligo and his BB scheme (a full 180 turn around on the BB issue and likely done to raise the SP before the AGM2024) be enough to appease the main players to see this bio pharmaceutical “conductor” fend off the (baton snapping!) second strike that’s fast approaching ?

    Last edited by Melon felon!: 18/04/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.16
Change
-0.050(0.33%)
Mkt cap ! $758.0M
Open High Low Value Volume
$15.20 $15.21 $14.90 $606.6K 40.13K

Buyers (Bids)

No. Vol. Price($)
1 150 $15.15
 

Sellers (Offers)

Price($) Vol. No.
$15.20 860 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$15.14
  Change
-0.050 ( 0.16 %)
Open High Low Volume
$15.11 $15.21 $14.95 4220
Last updated 15.59pm 13/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.